NOVEL OCTAHYDROTHIENOQUINOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING DERIVATIVE, AND USE OF THESE
申请人:Nishimura Toshihiro
公开号:US20140243311A1
公开(公告)日:2014-08-28
The present invention provides compounds represented by the general formula (I): or pharmaceutical acceptable salts thereof, wherein R
1
is cyano or the like; R
2
and R
3
are hydrogen or the like; R
4
is C
1-6
alkyl or the like; R
5
is C
1-6
alkyl, halo-C
1-6
alkyl, cycloalkyl, cycloalkyl-C
1-6
alkyl, aralkyl or the like; R
6
and R
7
are each hydrogen, C
1-6
alkyl, halo-C
1-6
alkyl, cycloalkyl, C
1-6
alkoxy-C
1-6
alkyl, R
12
R
13
N—C
1-6
alkyl or the like, which exhibit potent dopamine D
2
receptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
本发明提供了通式(I)所代表的化合物或其药物可接受的盐,其中R1是氰基或类似物;R2和R3是氢或类似物;R4是C1-6烷基或类似物;R5是C1-6烷基,卤代C1-6烷基,环烷基,环烷基-C1-6烷基,芳基烷基或类似物;R6和R7分别是氢,C1-6烷基,卤代C1-6烷基,环烷基,C1-6烷氧基-C1-6烷基,R12R13N-C1-6烷基或类似物,具有强效的多巴胺D2受体刺激活性。本发明还提供了含有该化合物的药物组合物及其用途。